The CD4-dominated inflammatory infiltrate in MOGAD differentiates this disease from MS, in which inflammatory infiltrates are mainly composed of CD8+ T-cells, as shown in large cohort studies including all disease stages [49, 71]. The gene discussed is CD8A; the disease is myeloid sarcoma.